Induced pluripotent stem cells from a spinal muscular atrophy patient.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 19098894.
- Also identified by DOI 10.1038/nature07677 and PMC identifier 2659408.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Spinal muscular atrophy is one of the most common inherited forms of neurological disease leading to infant mortality. Patients have selective loss of lower motor neurons resulting in muscle weakness, paralysis and often death. Although patient fibroblasts have been used extensively to study spinal muscular atrophy, motor neurons have a unique anatomy and physiology which may underlie their vulnerability to the disease process. Here we report the generation of induced pluripotent stem cells from skin fibroblast samples taken from a child with spinal muscular atrophy. These cells expanded robustly in culture, maintained the disease genotype and generated motor neurons that showed selective deficits compared to those derived from the child's unaffected mother. This is the first study to show that human induced pluripotent stem cells can be used to model the specific pathology seen in a genetically inherited disease. As such, it represents a promising resource to study disease mechanisms, screen new drug compounds and develop new therapies.
Medical subject headings
- Cellular Reprogramming
- Fibroblasts
- Models, Biological
- Motor Neurons
- Muscular Atrophy, Spinal
- Pluripotent Stem Cells